======= CLK2 ======= == Gene Information == * **Official Symbol**: CLK2 * **Official Name**: CDC like kinase 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=1196|1196]] * **UniProt**: [[https://www.uniprot.org/uniprot/P49760|P49760]] * **Interactions**: [[https://thebiogrid.org/search.php?search=CLK2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CLK2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/602989|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex. May be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing and can cause redistribution of SR proteins from speckles to a diffuse nucleoplasmic distribution. Acts as a suppressor of hepatic gluconeogenesis and glucose output by repressing PPARGC1A transcriptional activity on gluconeogenic genes via its phosphorylation. Phosphorylates PPP2R5B thereby stimulating the assembly of PP2A phosphatase with the PPP2R5B-AKT1 complex leading to dephosphorylation of AKT1. Phosphorylates: PTPN1, SRSF1 and SRSF3. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells. {ECO:0000269|PubMed:10480872, ECO:0000269|PubMed:19168442, ECO:0000269|PubMed:8910305, ECO:0000269|PubMed:9637771}. |Pkinase Tyr| |Pkinase| |negative regulation of gluconeogenesis| |protein serine/threonine/tyrosine kinase activity| |negative regulation of cellular carbohydrate metabolic process| |regulation of gluconeogenesis| |negative regulation of carbohydrate metabolic process| |protein tyrosine kinase activity| |negative regulation of small molecule metabolic process| |regulation of carbohydrate biosynthetic process| |response to retinoic acid| |regulation of glucose metabolic process| |regulation of RNA splicing| |regulation of cellular carbohydrate metabolic process| |peptidyl-tyrosine phosphorylation| |peptidyl-tyrosine modification| |response to ionizing radiation| |protein autophosphorylation| |regulation of carbohydrate metabolic process| |nuclear body| |response to acid chemical| |protein serine/threonine kinase activity| |nuclear speck| |regulation of small molecule metabolic process| |response to radiation| |response to lipid| |peptidyl-amino acid modification| |protein phosphorylation| |identical protein binding| |response to abiotic stimulus| |phosphorylation| |ATP binding| |negative regulation of cellular biosynthetic process| |negative regulation of biosynthetic process| |response to oxygen-containing compound| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp501|Methotrexate 0.01μM R08 exp501]]|-1.76| |[[:results:exp45|Docetaxel 0.002μM R01 exp45]]|2.42| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 2/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|1/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 3425 * **Expression level (log2 read counts)**: 6.67 {{:chemogenomics:nalm6 dist.png?nolink |}}